Iron overload among a psychiatric outpatient population

Journal of Clinical Psychiatry

Volumn 58, Issue 2, 1997, Pages 74-78

  Feifel, David ^a   Young, Corinna W ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; CARBAMAZEPINE; DEFEROXAMINE; DEFEROXAMINE MESYLATE; FERRITIN; IRON; LITHIUM; VALPROIC ACID; VERAPAMIL;

ADULT; ARTICLE; CLINICAL ARTICLE; DEPRESSION; DISEASE PREDISPOSITION; FEMALE; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; IRON BLOOD LEVEL; IRON OVERLOAD; MALE; MANIC DEPRESSIVE PSYCHOSIS; MENTAL DISEASE; MENTAL PATIENT; NEUROTRANSMISSION; OUTPATIENT; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0031029196     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.v58n0204     Document Type: Article

References (18)

1. Edwards CQ, Dadone MM, Skolnick MH, et al. Hereditary hemochromatosis. Clinics in Haematology 1982;11(2):411-435
2. Ben-Shachar D, Finberg JPM, Youdim MBH. Effect of iron chelators on dopamine D2 receptors. J Neurochem 1985;45:999-1005
3. Youdim MBH, Ben-Shachar D, Yehuda S. Putative biological mechanisms of the effect of iron deficiency on brain biochemistry and behavior. Am J Clin Nutr 1989;50:607-633
4. Youdim MBH, Ben-Schahar D, Riedere P. Iron in brain function and dysfunction with emphasis on Parkinson's disease. Eur Neurology 1991;31(suppl 1):34-40
5. Moffett D, Moffett S, Schauf C. Human Physiology: Foundations and Frontiers. St. Louis, Mo: Mosby; 1993
6. Pippard MJ. Secondary iron overload. In: Brock JH, Halliday JW, Poppard MJ, et al, eds. Iron Metabolism in Health and Disease. London, England: Saunders; 1994:272-308
7. Gutteridge JMC, Richmond R, Halliwell B. Inhibition of the iron-catalyzed formation of hydroxy radicals from superoxide and lipid peroxidation by desferrioxamine. Biochem J 1979;184:469-472
8. Dexter DT, Jenner P, Schapira AH, et al. Alterations in levels of iron, ferritin and other trace metals in neurodegenerative diseases affecting the basal ganglia. Ann Neurol 1992;32(suppl):S94-S100
9. Sachdev P. The neurochemistry of brain iron. J Neuropsychiatry Clin Neurosci 1993;5(1):18-29
10. Niederau C, Fischer R, Sonnenberg A, et al. Survival and causes of death in cirrhotic and non-cirrhotic patients with primary hematochromatosis. N Engl J Med 1985;313:1256-1262
11. Cutler P. Iron overload in psychiatric illness. Am J Psychiatry 1991;148: 148-149
12. Cutler P. Iron overload in psychiatric illness. Can J Psychiatry 1994;39: 8-11
13. Custer EM, Fince AC, Sobel RE, et al. Population norms for serum ferritin. J Lab Clin Med 1995;126:88-94
14. Tietz NW, Rinker AD, Morrison SR. When is serum iron really a serum iron? the status of serum iron measurements. Clin Chem 1994;40: 546-551
15. Garcia-Webb P. Transferrin index: an alternative method for calculating the iron saturation of transferrin. 1992;38:2078-2081
16. Cox TM, Lord DK. Hereditary haemachromatosis. Eur J Haematol 1989;42:113-125
17. Fava M, Labbate LA, Abraham ME, et al. Hypothyroidism and hyperthyroidism in major depression revisited. J Clin Psychiatry 1995;56:186-192
18. Young N, Henry W, Nienhuis W. Treatment of primary hemochromatosis with deferoxamine. JAMA 1979;24:1152-1154